Efficacy and tolerability of the new antiepileptic drugs: Comparison of two recent guidelines

Lancet Neurology

Volumn 3, Issue 10, 2004, Pages 618-621

  Beghi, Ettore ^a,b  

^a SAN GERARDO HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGGRESSION; ANHIDROSIS; ANOREXIA; APLASTIC ANEMIA; ARTHRITIS; ASTHENIA; BEHAVIOR DISORDER; BONE MARROW TOXICITY; COGNITION; CONGENITAL MALFORMATION; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EPILEPSY; EPILEPTIC STATE; HUMAN; HYPERSENSITIVITY; HYPONATREMIA; INSOMNIA; IRRITABILITY; KIDNEY FAILURE; LANGUAGE DISABILITY; LIVER FAILURE; LIVER TOXICITY; METABOLIC ACIDOSIS; NEPHROLITHIASIS; OPEN ANGLE GLAUCOMA; PARESTHESIA; PERIPHERAL EDEMA; PHOTOSENSITIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSIS; RASH; REVIEW; STEVENS JOHNSON SYNDROME; TIC; TOXIC EPIDERMAL NECROLYSIS; UNITED KINGDOM; UNITED STATES; VISUAL FIELD DEFECT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 4544246619     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(04)00882-8     Document Type: Short Survey

References (12)

1. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 34:1993;453-468
2. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia. 32:1991;429-445
3. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy. Neurology. 62:2004;1252-1260
4. French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy. Neurology. 62:2004;1261-1273
5. National Institute for Clinical Excellence. Newer drugs for epilepsy in adults. www.nice.org.uk/Docref.asp?d=110081 (accessed Aug 31, 2004).
6. National Institute for Clinical Excellence. Newer drugs for epilepsy in children. www.nice.org.uk/Docref.asp?d=113359 (accessed Aug 31, 2004).
7. French J, Smith M, Faught E, Brown L. Practice advisory: the use of felbamate in the treatment of patients with intractable epilepsy. Neurology. 52:1999;1540-1545
8. Wong ICK, Lhatoo SD. Adverse reactions to new anticonvulsant drugs. Drug Saf. 23:2000;35-56
9. Sheridan PH, Jacobs MP. The development of antiepileptic drugs for children: report from the NIH workshop, Bethesda, MD, Feb 17-18, 1994. Epilepsy Res. 23:1996;87-92
10. Beghi E, Annegers JF for the Collaborative Group for the Pregnancy Registries in Epilepsy. Epilepsia 2001; 42: 1422-1425.
11. Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy. www.sign.ac.uk/pdf/sign70.pdf (accessed July 31, 2004).
12. Karceski S, Morrell M, Carpenter D. The expert consensus guideline series: treatment of epilepsy. Epilepsy Behav. 2:2001;A1-50